Published in Fam Cancer on January 01, 2001
The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology (2008) 3.35
Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg? Hum Genet (2008) 1.81
Novel PMS2 pseudogenes can conceal recessive mutations causing a distinctive childhood cancer syndrome. Am J Hum Genet (2004) 1.58
PMS2 monoallelic mutation carriers: the known unknown. Genet Med (2015) 1.44
Syndrome of early onset colon cancers, hematologic malignancies & features of neurofibromatosis in HNPCC families with homozygous mismatch repair gene mutations. Fam Cancer (2005) 1.16
The E705K mutation in hPMS2 exerts recessive, not dominant, effects on mismatch repair. Cancer Lett (2006) 1.15
A homozygous MSH6 mutation in a child with café-au-lait spots, oligodendroglioma and rectal cancer. Fam Cancer (2004) 1.00
Higher occurrence of childhood cancer in families with germline mutations in BRCA2, MMR and CDKN2A genes. Fam Cancer (2008) 1.00
Inherited predisposition to glioma. Neuro Oncol (2009) 0.99
A homozygote splice site PMS2 mutation as cause of Turcot syndrome gives rise to two different abnormal transcripts. Fam Cancer (2008) 0.91
Thyroid cancer in a patient with a germline MSH2 mutation. Case report and review of the Lynch syndrome expanding tumour spectrum. Hered Cancer Clin Pract (2008) 0.85
Polyposis and early cancer in a patient with low penetrant mutations in MSH6 and APC: hereditary colorectal cancer as a polygenic trait. Int J Colorectal Dis (2006) 0.84
Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis. PLoS Genet (2014) 0.80
Compound heterozygosity for two MSH2 mutations suggests mild consequences of the initiation codon variant c.1A>G of MSH2. Eur J Hum Genet (2008) 0.78
Hereditary Colorectal Cancer: Genetics and Screening. Surg Clin North Am (2015) 0.77
Non-Hodgkin lymphoma risk and variants in genes controlling lymphocyte development. PLoS One (2013) 0.75
A rare case of Crohn's ileitis in a patient with constitutional mismatch repair deficiency. Ann Gastroenterol (2017) 0.75
Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology (1997) 9.70
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology (1994) 8.79
Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet (2001) 6.36
Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology (2000) 5.40
Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet (1997) 4.86
The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med (1997) 4.66
Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med (1987) 4.55
Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann Intern Med (1986) 4.18
Molecular diagnosis of familial adenomatous polyposis. N Engl J Med (1993) 4.07
Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res (1996) 3.60
The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology (1992) 3.59
The APC gene product in normal and tumor cells. Proc Natl Acad Sci U S A (1993) 3.25
Genetic instability occurs in the majority of young patients with colorectal cancer. Nat Med (1995) 3.07
A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet (2004) 3.05
Lymphocytic ("microscopic") colitis: a comparative histopathologic study with particular reference to collagenous colitis. Hum Pathol (1989) 3.02
Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival. Ann Oncol (2008) 2.97
Collagenous colitis with mucosal tears on endoscopic insufflation: a unique presentation. Gut (2002) 2.81
Inhibition of apoptosis during development of colorectal cancer. Cancer Res (1995) 2.77
AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology (2001) 2.63
Attenuated familial adenomatous polyposis (AFAP). A phenotypically and genotypically distinctive variant of FAP. Cancer (1995) 2.53
hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res (1994) 2.39
The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations. J Med Genet (2004) 2.10
Desmoid tumours in familial adenomatous polyposis. Gut (1994) 2.08
Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res (2001) 1.98
Chronic colitis with thickening of the subepithelial collagen layer (collagenous colitis): histopathologic findings in 15 patients. Hum Pathol (1987) 1.97
Hepatoblastoma and APC gene mutation in familial adenomatous polyposis. Gut (1996) 1.89
Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology (2000) 1.86
The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology (1995) 1.86
Variable phenotype of familial adenomatous polyposis in pedigrees with 3' mutation in the APC gene. Gut (1998) 1.85
Familial empiric risk estimates of inflammatory bowel disease in Ashkenazi Jews. Gastroenterology (1989) 1.80
Prevalence and importance of pigmented ocular fundus lesions in Gardner's syndrome. N Engl J Med (1987) 1.76
Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome. Cancer Res (1998) 1.73
HLA-DQ alpha allele and genotype frequencies in various human populations, determined by using enzymatic amplification and oligonucleotide probes. Am J Hum Genet (1990) 1.72
Decreased expression of the gut-enriched Krüppel-like factor gene in intestinal adenomas of multiple intestinal neoplasia mice and in colonic adenomas of familial adenomatous polyposis patients. FEBS Lett (2000) 1.70
Geographic origins of Jewish patients with inflammatory bowel disease. Gastroenterology (1989) 1.63
Sporadic fundic gland polyps: common gastric polyps arising through activating mutations in the beta-catenin gene. Am J Pathol (2001) 1.61
Rectal epithelial apoptosis in familial adenomatous polyposis patients treated with sulindac. Gut (1999) 1.59
Sulindac targets nuclear beta-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines. Br J Cancer (2004) 1.54
Familial pancreatic cancer. Cancer J (2001) 1.51
Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N'-nitro-N-nitrosoguanidine. J Clin Invest (1996) 1.49
Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation. Gastroenterology (1994) 1.48
Spinal muscular atrophy variant with congenital fractures. Am J Med Genet (1999) 1.47
Fundic gland polyps in familial adenomatous polyposis: neoplasms with frequent somatic adenomatous polyposis coli gene alterations. Am J Pathol (2000) 1.44
Mucosal prolapse in the pathogenesis of Peutz-Jeghers polyposis. Gut (2006) 1.42
Large genomic deletions of SMAD4, BMPR1A and PTEN in juvenile polyposis. Gut (2008) 1.41
p53 protein expression and gene analysis in clear cell adenocarcinoma of the vagina and cervix. Gynecol Oncol (1996) 1.40
Geographical variance in the risk of gastric stump cancer: no increased risk in Japan? Jpn J Cancer Res (1991) 1.39
A filing system for the gastroenterology/hepatology consultant. Am J Gastroenterol (1995) 1.39
Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol (2012) 1.35
Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposis. Ann Surg Oncol (2002) 1.34
Familial pancreatic cancer. Ann Oncol (1999) 1.33
Collagenous colitis: physiologic and histopathologic studies in seven patients. Ann Intern Med (1987) 1.32
Screening for germ-line mutations in familial adenomatous polyposis patients: 61 new patients and a summary of 150 unrelated patients. Hum Mutat (1992) 1.30
Health beliefs and endoscopic screening for colorectal cancer: potential for cancer prevention. Prev Med (2001) 1.30
Distribution of 13 truncating mutations in the neurofibromatosis 1 gene. Hum Mol Genet (1995) 1.30
Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol (2011) 1.29
Familial Mediterranean fever in Armenians: autosomal recessive inheritance with high gene frequency. Am J Med Genet (1989) 1.29
Phenotypic expression of disease in families that have mutations in the 5' region of the adenomatous polyposis coli gene. Ann Intern Med (1997) 1.29
MUC-2 human small intestinal mucin gene structure. Repeated arrays and polymorphism. J Clin Invest (1991) 1.26
Attitudes toward colon cancer gene testing: factors predicting test uptake. Cancer Epidemiol Biomarkers Prev (1999) 1.26
A genetic association study of 5-HTT LPR and GNbeta3 C825T polymorphisms with irritable bowel syndrome. Neurogastroenterol Motil (2007) 1.23
Size-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis. Cancer Res (1998) 1.23
The value of immunohistochemistry for collagen IV expression in colorectal carcinomas. Cancer (1991) 1.22
The Tay-Sachs disease gene in North American Jewish populations: geographic variations and origin. Am J Hum Genet (1983) 1.22
Pigmented ocular fundus lesions in the inherited gastrointestinal polyposis syndromes and in hereditary nonpolyposis colorectal cancer. Ophthalmology (1988) 1.21
A multicenter proficiency trial of gene amplification (PCR) for the detection of HIV-1. J Acquir Immune Defic Syndr (1991) 1.21
Irritable bowel syndrome aggregates strongly in families: a family-based case-control study. Neurogastroenterol Motil (2008) 1.19
Effect of polyamine depletion on c-myc expression in human colon carcinoma cells. J Biol Chem (1988) 1.19
Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention. Gastroenterol Clin North Am (1996) 1.18
Genetic testing and counseling for hereditary forms of colorectal cancer. Cancer (1999) 1.16
Genetic alterations and epithelial dysplasia in juvenile polyposis syndrome and sporadic juvenile polyps. Am J Pathol (1997) 1.15
Meta-analysis of the risk of gastric stump cancer: detection of high risk patient subsets for stomach cancer after remote partial gastrectomy for benign conditions. Cancer Res (1990) 1.14
Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome. Clin Cancer Res (2000) 1.12
Cigar and pipe smoking, smokeless tobacco use and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol (2011) 1.10
Prevention and management of duodenal polyps in familial adenomatous polyposis. Gut (2005) 1.09
Automatic regulation of the cuff pressure in endotracheally-intubated patients. Eur Respir J (2002) 1.09
Pitfalls in the diagnosis of collagenous colitis: experience with 75 cases from a registry of collagenous colitis at the Johns Hopkins Hospital. Hum Pathol (1990) 1.09
Lymphocytic enterocolitis in patients with 'refractory sprue'. JAMA (1989) 1.09
Tissue prostanoids as biomarkers for chemoprevention of colorectal neoplasia: correlation between prostanoid synthesis and clinical response in familial adenomatous polyposis. Prostaglandins Other Lipid Mediat (2000) 1.08
Evaluation of endoscopy for early detection of gastric-stump cancer. Lancet (1992) 1.06
NIH consensus development statement on management of hepatitis B. NIH Consens State Sci Statements (2009) 1.06
Multivariate analysis of the risk of stomach cancer after ulcer surgery in an Amsterdam cohort of postgastrectomy patients. Am J Epidemiol (1991) 1.06
Cystic fibrosis transmembrane regulator gene carrier status is a risk factor for young onset pancreatic adenocarcinoma. Gut (2005) 1.05
Cancer risk in collagenous colitis. Inflamm Bowel Dis (1999) 1.05
Genetics of pancreatic cancer. From genes to families. Surg Oncol Clin N Am (1998) 1.05
Oral and maxillofacial manifestations of familial adenomatous polyposis. Oral Dis (2007) 1.05
Relationships between the human pepsinogen DNA and protein polymorphisms. Am J Hum Genet (1986) 1.03